Tag | Content |
---|
EnhancerAtlas ID | HS193-00625 |
Organism | Homo sapiens |
Tissue/cell | U87 |
Coordinate | chr1:27424440-27425290 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nr2f6(var.2) | MA0728.1 | chr1:27424515-27424530 | TGAACTCCTGACCTC | - | 6.22 |
|
| Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
SE_08182 | chr1:27425069-27426923 | Brain_Inferior_Temporal_Lobe | SE_09350 | chr1:27423956-27427835 | CD14 | SE_31553 | chr1:27424644-27427446 | Gastric | SE_37352 | chr1:27424732-27427270 | HSMMtube | SE_41510 | chr1:27424454-27427884 | Left_Ventricle | SE_42522 | chr1:27424544-27427894 | Lung | SE_50517 | chr1:27424763-27426976 | Sigmoid_Colon | SE_52500 | chr1:27425172-27427288 | Small_Intestine | SE_53642 | chr1:27424607-27427217 | Spleen |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I027098 | chr1 | 27424561 | 27428202 |
|
Enhancer Sequence | CATACATCAC CATGCCCAGC TAATTTTTGT ATTTTTAGTA GAGATGGGGT TTTGCCATGT 60 TGGCCAGGCT GGTCTTGAAC TCCTGACCTC AGGTGATCCG CCCAGCTTGG CCTCCCAAAG 120 TGCTGGGATT ACAGGCATGA GCCACCGCGC CCGGCCCAAT TTTATATATT TTAAATATTG 180 CACATGCAGC AAAGTTTTGA CTGTCTCATG AGGTCAGGTG TGCATTCTCC ATTCATGGCG 240 TTGTGTTGGG TTTTCTGATT AGGGAGGCTC AGTTTGTACA CACCTGAGCT TATCTCATGC 300 AGGGGTCACT GTCCCCACTT TACAGGTGAG AACTTGAGGG CTTCAGTGAC TTCCCACTGC 360 CCTTTTGGTC TTCCCACGGT TAAGAGCAAA ATCTTAACCA TGGAGCACGC GGCCCCATCC 420 TTGCCTCCCC TGTCACTCTG ACCCAGCCAC CCGGCCTTTT CTCAGGTCCC AGTGTTCGTG 480 GGCACAGCTC CCAGTTACAA TGTTTGGGAA CTTTCTGGGT CCTTTTCCAC CCGGAAGCCT 540 TGGCTCCTTC TTCAGTCCCC TCCTGGGATC TCACTCACTC GGGACTCAGG AGGGTCCTCC 600 TCGCCGTCCC TCCCTCCCCT CTGCCTCTTT TTCACCTCTT GCACAAACAC TGGGCACTGG 660 TTAGTGCCGC TCTCCCCCGC GGGGCAGGGC ACGTCCTGCT TAGCTCATTG TGGTATCTCA 720 GTGCCTGGCA TGTGGGAACA ACCACCCCAG CAGCTGACAG CCATGAAGTG TTTCTGTGCC 780 AGCCTTTGAA CTAAGTACTT CACGCCCTCA GGCCACCCTC CCTCCTAAAG ACCCTCGTCC 840 CCAGAAAGCA 850
|